Safety, Pharmacokinetics, and Preliminary Antitumor Activity of Sorafenib: A Review of Four Phase I Trials in Patients with Advanced Refractory Solid TumorsDirk Strumberg, Brian Schwartz, Heike Richly et al.|The Oncologist|2007Cited by 418
The neuroepithelial origin of ovarian carcinomas explained through an epithelial-mesenchymal-ectodermal transition enhanced by cisplatinDavid Díaz-Carballo, Dirk Strumberg, Ayesha Safoor et al.|Scientific Reports|2024Cited by 4